D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: An EORTC Gynaecological Cancer Co-operative Group Study

Anti-Cancer Drugs

Volumn 12, Issue 2, 2001, Pages 159-162

  Duffaud, F ^a   Van Der Burg, M E L ^b   Namer, M ^c   Vergote, I ^d   Willemse, P B ^e   Ten Bokkel Huinink, W ^e   Guastalla, J P ^e   Nooij, M A ^e   Kerbrat, P ^e   Piccart, M ^f,j   Tumolo, S ^g,k   Favalli, G ^h,l   Van Der Vange, N ^f,i   Lacave, A J ^m   Wils, J ⁿ   Splinter, T A W ^b   Einhorn, N ^o   Roozendaal, K J ^p   Rosso, R ^q   Vermorken, J B ^r  

^a EORTC DATA CENTER   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CENTRE ANTOINE LACASSAGNE   (France)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^g CENTRE LÉON BÉRARD   (France)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ CENTRE EUGÈNE MARQUIS   (France)

^j JULES BORDET INSTITUTE   (Belgium)

^k S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^l UNIVERSITY OF BRESCIA   (Italy)

^m HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

ⁿ LAURENTIUS HOSPITAL   (Netherlands)

^o KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^p ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^q UNIVERSITY OF GENOA   (Italy)

^r ANTWERP UNIVERSITY HOSPITAL   (Belgium)

more..

Author keywords

Hormonal therapy; Luteinizing hormone releasing hormone; Ovarian cancer; Triptorelin

Indexed keywords

GONADORELIN AGONIST; TRIPTORELIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; MICROENCAPSULATION; OVARY CARCINOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA; DRUG EVALUATION; DRUG RESISTANCE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PLATINUM COMPOUNDS; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; TRIPTORELIN;

EID: 0035090073     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200102000-00010     Document Type: Article

References (25)

1. Endocrine factors in common epithelial ovarian cancer
2. Inhibitory effect of GnRH superagonist on the growth of human ovarian carcinoma NIH: OVCAR 3 in the nude mouse
3. LHRH agonist treatment in ovarian cancer
4. The use of luteinizing hormone releasing hormone agonists and antagonists in gynecological cancers
5. Development of tumors in rat ovary after transplantation into the spleen
6. Primary and salvage therapy with LH-RH analogues in ovarian cancer
7. Antitumor effect of GnRH agonist in epithelial ovarian cancer
8. GnRH-binding sites in human epithelial ovarian carcinoma
9. Insulin-like growth factor-II participates in the biphasic effect of a gonadotropin-releasing hormone agonist on ovarian cancer cell growth
10. Gonadptropin releasing hormone binding sites in epithelial ovarian carcinoma
11. Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma
12. Gonadotropin-releasing hormone receptor in gynecologic tumors, frequent expression in adenocarcinoma histologic types
13. Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer
14. Therapy of advanced ovarian cancer with D-Trp-6-LH-RH (decapeptyl) microcapsules
15. Some observations on the effect of a GnRH analog in ovarian cancer
16. Treatment of advanced refractory ovarian carcinoma with a gonadotropin-releasing hormone analogue
17. Leuprolide acetate in the treatment of refractory or persistent epithelial ovarian cancer
18. A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer
19. Goserelin a GnRH-analogue as third-line therapy of refractory epithelial ovarian cancer
20. A randomized comparison of Triptorelin and Tamoxifen as treatment of progressive ovarian cancer
21. The treatment of progressive ovarian carcinoma with D-Trp-LHRH (decapeptyl)
22. Experience with hormonal therapy in advanced epithelial ovarian cancer
23. Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75
24. Analogues of luteinizing hormone releasing hormone containing cytotoxic groups